Antwerp, June 22, 2026 (GLOBE NEWSWIRE) -- CMB.TECH NV (“CMBT”, “CMB.TECH” or “the company”) (NYSE: CMBT, Euronext Brussels: CMBT and Euronext Oslo Børs : CMBTO) and Fortescue have signed
The Lanier Law Firm attorney Mark Lanier discusses Roblox's new safety measures, online child protection and Florida's lawsuit against TikTok on ‘Varney & Co.' #foxbusiness #varneyandco 00:00 — Ma
CMBT.TECH transformed post-Golden Ocean merger, evolving from a tanker-focused play to a diversified shipping platform with over 250 vessels. Current tanker and dry bulk markets are both robust, drivi
Techne (TECH) reported earnings 30 days ago. What's next for the stock?
New integrated workflow combines icIEF fractionation and mass photometry Enables direct characterization of aggregation and size within icIEF-resolved charge variants Four-hour workflow reduces devel

CMB.TECH RESULTS GENERAL MEETINGS

11:39am, Thursday, 21'st May 2026
Antwerp, May 21, 2026 (GLOBE NEWSWIRE) -- CMB.TECH  NV (“ CMBT ”, “ CMB.TECH ” or “the  c ompany”)  (NYSE: CMBT, Euronext Brussels: CMBT and Euronext Oslo  Børs : CMBTO) announces th
CMB.TECH NV (CMBT) Q1 2026 Earnings Call Transcript

CMB.TECH Q1 Earnings Call Highlights

11:08am, Tuesday, 19'th May 2026
CMB.TECH NYSE: CMBT reported a strong first quarter of 2026, with management highlighting higher revenue, reduced leverage, lower financing costs and substantial gains from vessel sales during an earn

CMB.TECH announces Q1 2026 results

01:01am, Tuesday, 19'th May 2026
CMB.TECH ANNOUNCES Q1 2026 RESULTS FIRING ON ALL CYLINDERS ANTWERP, Belgium, 19 May 2026 – CMB.TECH NV (“CMBT”, “CMB.TECH” or “the company”) (NYSE: CMBT, Euronext Brussels: CMBT and Euro
Bio-Techne Corporation (TECH) Presents at Bank of America Global Healthcare Conference 2026 Transcript

CMB.TECH announces Q1 2026 results on 19/05/2026

01:58am, Thursday, 07'th May 2026
ANTWERP, Belgium, 7 May 2026 – CMB.TECH NV  (NYSE: CMBT, Euronext Brussels: CMBT and Euronext Oslo Børs: CMBTO) (“CMBT”, “CMB.TECH” or “the Company”) will release its first quarter 202
Bio-Techne Corporation (TECH) Q3 2026 Earnings Call Transcript
Bio-Techne slips after Q3 EPS miss and revenue decline, despite operating margin expansion and strong growth in key segments.
Techne (TECH) came out with quarterly earnings of $0.53 per share, missing the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $0.56 per share a year ago.
Biotech firm Bio-Techne on Wednesday missed Wall Street estimates for third-quarter revenue, as cuts to U.S. ​academic funding weighed on demand for its drug-development ‌products.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE